REGENERON PHARMACE REGN (NASDAQ)

$ 18.92
19:09
Change: -0.92 (-4.64%)
Volume: 563,200

Avg. Volume: 700475
P/E Ratio: 0
EPS (Annual): -1.11
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 78,990
Institutional Shareholders: 76.84%
Last: 18.92
Change: -0.92 (-4.64%)
Prev. Close: 19.84
Open: 20.17
Day's Range: 18.74 - 20.83
52wk Range: 13.29 - 25.25
Market Value: 1,661,350
Beta: 1.42
12-month EPS Change: 0.00%
Total Return Last 12 Months: +10.41%
Total Return Last 3 Years: +58.15%
Total Return Last 5 Years: +37.40%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on REGN

Regeneron reports positive results from gout study

(TARRYTOWN, N.Y.)Regeneron Pharmaceuticals said Wednesday its drug Arcalyst showed positive results at treating the painful inflammatory disease gout in midstage trials.READ MORE
Sep 03, 2008 1:03PM
Keywords: REGN

Regeneron and Bayer report follow-up eye drug data

(TARRYTOWN, N.Y.)Regeneron Pharmaceuticals Inc. and Bayer HealthCare AG said Tuesday their drug candidate VEGF Trap-Eye continued to benefit patients with macular degeneration, which can lead to bl...READ MORE
Aug 19, 2008 9:03AM
Keywords: REGN

Analyst says Regeneron oversold on drug failure

(NEW YORK)A Lehman Brothers analyst said Regeneron Pharmaceuticals Inc.'s cancer drug aflibercept compares more favorably with Genentech Inc.'s Avastin than investors realize.READ MORE
Jun 06, 2008 5:11PM
Keywords: REGN, DNA, SNY

Movers Roundup: Cooper, Tumbleweed

Among the stock activity stories for Friday, June 6, from AP Financial News: NEW YORK (AP)--Shares of specialty contact lens maker Cooper Cos. fell Friday, despite posting fiscal s...READ MORE
Jun 06, 2008 2:56PM
Keywords: COO, TMWD, REGN, DNA

S&P SmallCap 600 in Focus: HOTT REGN

(NEW YORK)The Standard & Poor's SmallCap 600 Index advanced on Thursday, led by Hot Topic Inc. after the teen apparel retailer said its May same-store sales fell less than expected.READ MORE
Jun 05, 2008 1:55PM
Keywords: HOTT, TRXB, COG, CRP, MS, MATK, TGI, REGN

Partnerships drive big stock gains for small biotechs

(NEW YORK)As growth slows in shares of large-cap biotechs and economic woes weigh on the broader markets, investors can find dramatic growth opportunities in many small and midcap biotechs w...READ MORE
May 21, 2008 4:58PM

Regeneron shares slide on missed cancer study goal

(NEW YORK)Shares of biopharmaceutical company Regeneron Pharmaceuticals Inc. fell sharply Wednesday after the company reported that a mid-stage trial of an ovarian cancer drug in development...READ MORE
May 21, 2008 4:46PM
Keywords: REGN, SNY, MS, CRP
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN -6.90 51.69
GILEAD SCIENCES -17.30 40.59
GENENTECH INC -0.30 78.19
CELGENE CP -24.10 55.88
BIOGEN IDEC INC -26.50 46.50